2′,7′-Dichlorofluorescein is not a probe for the detection of reactive oxygen and nitrogen species  by Reiniers, Megan J. et al.
Conﬂict of interest
The authors declared that they do not have anything to disclose
regarding funding or conﬂict of interest with respect to this
manuscript.
Reference
[1] Tritto G, Bechlis Z, Stadlbauer V, Davies N, Frances R, Shah N, et al. Evidence of
neutrophil functional defect despite inﬂammation in stable cirrhosis. J
Hepatol 2011;55:574–581.
Giovanni Tritto
Rajeshwar P Mookerjee
Rajiv Jalan⇑
Liver Failure Group, UCL Institute of Hepatology,
Royal Free Hospital, London, UK
⇑Corresponding author.
E-mail address: jalan@ucl.ac.uk (R. Jalan)
T
I
r
l
i
i
a
t
o
b
c
g
m
t
R
d
s
g
d
o
g
ﬂ
c
n
R
n
h
w
c
D
D
w
i
t
r
r
p
t
i
Letters to the Editor
120,70-Dichloroﬂuorescein is not a probe for the detection
of reactive oxygen and nitrogen specieso the Editor:
n a recent issue of this Journal, Llacuna and colleagues [1]
eported on the pivotal role of mitochondrial cholesterol accumu-
ation and aggravated oxidative stress in the pathophysiology of
schemia–reperfusion (IR) injury in the fatty liver. Steatotic mur-
ne livers were subjected to 60 min of warm ischemia followed by
non-speciﬁed period of reperfusion. During reperfusion, part of
he liver was incubated for 45 min with 200 lM 20,70-dichloroﬂu-
rescein (DCF) by means of superfusion and subsequently imaged
y in vivo confocal microscopy, whereby DCF ﬂuorescence was
onsidered a direct measure of reactive oxygen species (ROS)
eneration. The data obtained with this technique served as the
ain premises for the conclusions related to intrahepatic oxida-
ive stress.
However, DCF is not commonly used for the detection of ROS.
ather, the non-ﬂuorescent 20,70-dichlorodihydroﬂuorescein
iacetate (DCFH2-DA) is employed. DCFH2-DA enters cells by pas-
ive diffusion. Inside the cytosol, esterases remove the acetate
roups to form the non-ﬂuorescent derivative 20,70-dichlorodihy-
roﬂuorescein (DCFH2). Upon exposure to ROS as well as other
xidants such as reactive nitrogen species (RNS), DCFH2 under-
oes two-electron oxidation, resulting in generation of the highly
uorescent DCF (Fig. 1A). Accordingly, the extent of DCF ﬂuores-
ence can be employed as a measure of the degree of oxidative/
itrosative stress, i.e., a state in which the generation of ROS/
NS outweighs the cell’s antioxidative capacity [2].
Several experiments were performed to demonstrate the erro-
eous use of the probe. Firstly, the uptake of DCF by cultured
uman hepatocellular carcinoma (HepG2) cells was assessed. It
as shown that DCF indeed accumulates in HepG2 cells at con-
entrations >20 lM (Fig. 1B and C).
Next, transcapsular penetration and hepatocellular uptake of
CF were evaluated in vivo. Superfusion of murine livers with
CF for 45 min resulted in marginal tissue penetration at best,
ith DCF ﬂuorescence only exceeding background ﬂuorescence
ntensity at the capsular interface (Fig. 1D, arrow).
To investigate whether DCF ﬂuorescence increases upon oxida-
ion, as reported by Llacuna et al. [1], DCFwas incubatedwith Fenton
eaction-derived hydroxyl radicals (OH) [3]. A decrease in DCF ﬂuo-
escence emission was observed following the addition of hydrogen
eroxide (H2O2) to theDCF/iron(II)mixture,which led to the produc-
ion of OH (Fig. 1E) [3]. This is consistent with an earlier report that
dentiﬁedDCF as a target for oxidation [4], but unequivocally revokes
the conclusions of Llacuna and colleagues [1], who posited that DCF
ﬂuorescence intensiﬁes as ROS production increases.
Conclusively, the proposition that DCF functions as an indicator
for ROS production could not be conﬁrmed. Rather, the opposite
effects were observed, as evinced by the steep drop in DCF ﬂuores-
cence upon OH generation. The data hence refute the oxidative
stress-related conclusions by Llacuna et al. [1]. DCF is the end-
product of a free radical species-speciﬁc ﬂuorogenic probe (i.e.,
DCFH2-DA/DCFH2) rather than a probe for the direct visualization
of ROS/RNS. Moreover, DCF appears to be oxidized to a non-ﬂuo-
rescent, yet unidentiﬁed, compound in the presence of OH, reduc-
ing the ﬂuorescence intensity at 523 nm and thus reﬂecting an
underestimated extent of intracellular ROS/RNS production.
Apart from the apparent misuse and subsequent misinterpreta-
tion of the results, two additional issues should be addressed. First,
despite the fact that DCFH2-DA and DCFH2 are amongst the most
common probes for the detection of ROS/RNS, little is known about
the cellular behavior of these compounds. Although strongly stressed
bysome[5], studies that speciﬁcally investigateDCFH2-DAandderiv-
atives with respect to cellular kinetics, localization, and toxicity
remain scarce to date [6,7]. The elusive intracellular kinetics and
dynamics of DCFH2-DA and derivatives could lead to wrongful use
of the probe and hence misinterpretation of experimental results.
The second issue that exacts attention is the need to accu-
rately describe and perform experimental procedures so as to
ensure reproducibility and prevent the use of faulty methodolo-
gies, respectively. The incorrect use of materials or, for that mat-
ter, incorrect reporting on use of the proper materials (e.g.,
reporting on the use of DCF when actually DCFH2-DA was
employed instead), which can be found in various articles pub-
lished in 2010/11 alone [8–10], could lead to widespread misap-
plication of the probe and the erroneous formulation of
conclusions. This is especially important in regard to the data
of Llacuna et al. [1], where it appears that a conclusion was drawn
on the basis of incorrectly performed experiments.
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Fig. 1. DCF is not a probe for the detection of reactive oxygen and nitrogen species. (A) Chemical structures of DCFH2-DA and derivates at physiological pH. DCFH2-DA
(non-ﬂuorescent at 523 nm) is deacetylated (gray marquees, left panel) to DCFH2 by cytosolic esterases. DCFH2 (non-ﬂuorescent at 523 nm) undergoes a two-electron
oxidation (gray marquees, right panel) in the presence of ROS/RNS to yield DCF. DCF has an absorption maximum at 503 nm and an emission maximum at 523 nm in
aqueous solution. (B) Uptake of DCF by HepG2 cells. Cells were grown on ﬁbronectin-coated coverglass bottom dishes in William’s E (WE) medium supplemented with 10%
fetal bovine serum, 1% penicillin/streptomycin, 1% L-glutamine, 0.1% insulin, and 0.2% hydrocortisone. Following 1 h incubation in PBS or 50 lM DCF in PBS at 37 C, 5% CO2,
cells were washed and imaged by confocal microscopy at kex = 496 nm and kem = 525 ± 25 nm. PC, phase contrast; FL, ﬂuorescence; OV, overlay. (C) Quantiﬁcation of DCF
uptake by HepG2 cells as a function of DCF concentration. Cells were cultured on 24-well plates in supplemented WE medium as described above, washed, and incubated
with 0–50 lM DCF in unsupplemented WE medium for 1 h at 37 C, 5% CO2. Following incubation, cells were washed and cellular DCF ﬂuorescence was read with a
microplate reader at kex = 460 ± 40 nm and kem = 520 ± 20 nm. Fluorescence emission intensity was normalized to protein content. Statistical analysis was performed using
a one-way ANOVA and Dunnetts’s multiple comparison test following conﬁrmation of normal distribution of data with a D’Agostino and Pearson omnibus test. (D)
Superfusion of murine liver with DCF. The livers of adult male C57BL/6 mice (n = 3) were superfused with 60 ll of 200 lM DCF in PBS for 45 min. Subsequently, a punch
biopsy of the superfused liver section was histologically processed and imaged by confocal microscopy. DCF ﬂuorescence (kex = 496 nm and kem = 525 ± 25 nm) is shown in
green and TO-PRO 3 (kex = 633 nm and kem = 670 ± 30 nm) was used as a clear stain (red ﬂuorescence). (E) Oxidation-dependent DCF ﬂuorescence kinetics. A cuvette
containing 20 lM DCF and 2 mM Fe(II)SO4 in a 0.2 M Na2HPO4/0.1 M citric acid buffer (pH = 6 or pH = 7) (1485 ll total volume) was placed in a temperature-controlled
(20 C) spectroﬂuorometer set to kex = 500 ± 5 nm and kem = 523 ± 5 nm. During time-based acquisition, 15 ll of H2O2 (35.6 mM ﬁnal concentration) or an equivalent
volume of MilliQ was added at t = 1 min to the reaction mixture under continuous stirring. Addition of H2O2 resulted in the production of OH. Results represent the mean
ﬂuorescence emission values from n = 3 experiments per group. [This ﬁgure appears in color on the web.]
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Reply to: ‘‘20,70-Dichloroﬂuorescein is not a probe for the detection
of reactive oxygen and nitrogen species’’
To the Editor:
We received the letter by Rainiers et al. regarding our previous
work [1], with mixed feelings. We are grateful to these authors
for bringing to our attention the misspelling of the reagent used
to monitor hepatic oxidative stress in vivo during ischemia/
reperfusion (I/R) by two photon confocal imaging. However,
we regret that 20,70-dichloroﬂuorescein appeared in the experi-
mental procedures when in fact we actually used 20,70-dichloro-
ﬂuorescein diacetate (Sigma, Catalogue No. D6883), also known
as 20-70-dichlorodihydroﬂuorescein diacetate, a cell-permeable
non-ﬂuorescent probe that is de-esteriﬁed intracellularly and
converted to the highly ﬂuorescent 20,70-dichloroﬂuorescein
upon oxidation, to ultimately detect ROS/RNS. We hope this
unfortunate misspelling has not confused or misled researchers
working in I/R liver injury.
We appreciate the effort by Rainiers et al. to conﬁrm the
inability of 20,70-dichloroﬂuorescein to detect ROS/RNS, although
we believe investigators working in the ﬁeld of oxidative stress
for almost 30 years [2] know that 20,70-dichloroﬂuorescin diace-
tate or derivatives such as chloromethyl-20,70-dichlorodihydroﬂu-
orescein diacetate (Invitrogen, Catalogue No. C6827) are the
appropriate (reduced) substrates to monitor ROS/RNS, as
reported in an outstanding number of papers, including ours
[3–6].
While we apologize for the mistake, we regret the attempt of
Rainiers et al. to invalidate the conclusions of our study based on
the misspelling of the name of the probe, and not on the protocol
used. The confocal microscopy data show a clear mitochondrial
depolarization monitored with TMRM following I/R, particularly
in mice exhibiting increased cholesterol loading. More important,
the degree of hepatocellular damage monitored by transaminases
and H&E staining increased substantially following I/R in mice
exhibiting high hepatic cholesterol content, which was reduced
by strategies that decrease cholesterol loading, such as statins.
We believe our results report novel ﬁndings in the ﬁeld of liver
I/R injury, which may have important clinical implications for
the near future. Finally, we agree with Rainiers et al. that atten-
tion should be paid to avoid mistakes or misspellings in research
articles. In this regard, we welcome the initiative of some jour-
nals to include a detailed description of commercial products
used in the study such as the catalogue or CAS number, which
certainly will minimize future confusions.
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